Guides
Bone Density Around Menopause: What Clinical Research Says About Olive Oil
As estrogen levels fall, bone resorption accelerates — and researchers have begun asking whether the quality of dietary fat plays a role. A look at the clinical and nutritional-epidemiology evidence linking extra virgin olive oil to bone metabolism around menopause.
Translated from the Korean edition, originally published October 17, 2026 · read the original
Menopause and Bone — Why This Window Matters
A woman's bone density peaks in her mid-thirties and then begins a gradual decline. Around the five to seven years spanning menopause, however, that decline accelerates sharply. Estrogen normally suppresses excess osteoclast activity; as estrogen production falls after menopause, bone resorption begins to outpace bone formation. According to World Health Organization data, an estimated one in three women over 50 is at risk of experiencing an osteoporotic fracture.
Against that backdrop, researchers have started looking beyond calcium and vitamin D to ask whether the quality of dietary fat influences bone metabolism. Extra virgin olive oil (EVOO) — the primary fat source in the Mediterranean diet — has drawn particular attention.
Olive Oil and Bone Metabolism — What the Research Reports
One of the most-cited studies exploring this question is a sub-analysis of the PREDIMED (PREvención con DIeta MEDiterránea) trial, conducted by researchers at the University of Córdoba. Published in the Journal of Clinical Endocrinology & Metabolism in 2012, it reported that participants who maintained an olive-oil-rich Mediterranean diet for two years showed significantly higher levels of the bone-formation markers osteocalcin and P1NP (procollagen type I N-terminal propeptide) compared with the control group. The researchers proposed that the monounsaturated fatty acids (MUFAs) and polyphenols in olive oil may influence osteoblast activity, though they framed this as a hypothesis warranting further investigation.
A cross-sectional study of Moroccan women, published in PLOS ONE in 2016, reported a tendency toward higher lumbar bone density T-scores in the group with greater olive oil consumption frequency. The researchers themselves noted that because the study was cross-sectional in design, it is too early to conclude a causal relationship.
The Role of Polyphenols — Oleocanthal and Oleuropein
Among the bioactive compounds in olive oil, oleocanthal and oleuropein are most frequently discussed in the context of bone metabolism.
Oleocanthal is a phenolic compound structurally similar to ibuprofen. Cell and animal studies have reported that it can modulate inflammatory signalling through the COX-1 and COX-2 enzyme pathways. Because chronic low-grade inflammation is linked to the RANKL signalling cascade that stimulates osteoclasts, the hypothesis that anti-inflammatory dietary compounds may indirectly influence bone metabolism has been proposed in the literature — though this pathway has not been clearly confirmed in human clinical trials, and overinterpretation should be avoided.
Regarding oleuropein, researchers at the University of Patras used a rat model of post-menopausal bone loss and reported in the European Journal of Nutrition in 2012 that oleuropein supplementation was associated with an attenuation of bone mineral density decline. Whether these animal findings translate to humans requires separate clinical validation.
Oleic Acid and Bone-Formation Signalling
Oleic acid (C18:1), the principal fatty acid in olive oil, affects cell membrane fluidity and lipid raft composition. Multiple signalling pathways are involved in osteoblast differentiation and survival, and a body of research has reported that the fatty acid composition of cell membranes can influence the sensitivity of those pathways.
A meta-analysis published in Nutrients in 2020 reported that higher Mediterranean diet adherence scores were associated with more favourable osteoporosis-related markers. However, because the analysis treated the Mediterranean diet as a whole unit, isolating olive oil's independent contribution is not possible. The diet also includes vegetables, whole grains, fish, legumes, and other components that may each play a role.
Putting It Into Practice — What Specialists Suggest
Taking the current research as a whole, the most defensible approach is not to view olive oil as a stand-alone solution for bone health, but to use high-quality EVOO consistently as part of a broader Mediterranean dietary pattern.
Nutritional epidemiologists are commonly reported to suggest around 2–3 tablespoons (approximately 25–40 mL) of EVOO daily for perimenopausal women, used across cooking and dressings. Choosing products that declare both acidity and polyphenol content can help maintain a more consistent intake of bioactive compounds. Polyphenol levels vary considerably — from a few hundred mg/kg upward — depending on cultivar, harvest timing, and processing method, so reading the label carefully is worthwhile.
A dietary strategy aimed at bone health is reported to show the greatest benefit when high-quality fat intake is combined with adequate calcium, vitamin D, and protein, alongside weight-bearing exercise. Because appropriate dietary adjustments depend on individual bone density status and overall health, consultation with a qualified healthcare professional is important for a personalised approach.
Frequently asked questions
- Does olive oil help with bone loss during menopause?
- The evidence is promising but not conclusive. A sub-analysis of the PREDIMED trial published in the Journal of Clinical Endocrinology & Metabolism reported higher levels of bone-formation markers in women following an olive-oil-rich Mediterranean diet, and a 2016 cross-sectional study in PLOS ONE observed a positive association between olive oil intake frequency and lumbar bone density T-scores. However, it is too early to conclude that olive oil independently prevents bone loss, and no clinical guideline currently makes that claim.
- Which compounds in extra virgin olive oil are linked to bone health research?
- Oleocanthal and oleuropein are the two phenolic compounds most frequently discussed in this context. Oleocanthal has been reported in cell and animal studies to modulate inflammatory signalling via the COX-1 and COX-2 pathways. Oleuropein was studied in a rat model of post-menopausal bone loss by researchers at the University of Patras, with findings published in the European Journal of Nutrition in 2012 suggesting a slowing of mineral density decline — though animal results require separate human clinical validation.
- How much olive oil should perimenopausal women consume per day for bone health?
- There is no officially established therapeutic dose. Nutritional epidemiologists are commonly reported to suggest around 2–3 tablespoons (approximately 25–40 mL) of EVOO daily, integrated into cooking and dressings as part of a broader Mediterranean dietary pattern. Individual needs vary, and anyone adjusting their diet around bone health should consult a qualified healthcare professional.
- Is the Mediterranean diet as a whole better studied than olive oil alone for bones?
- Yes. A 2020 meta-analysis published in Nutrients found that higher adherence to the Mediterranean diet was associated with more favourable bone-health markers, but because the diet includes vegetables, whole grains, fish, legumes and other components alongside olive oil, isolating olive oil's specific contribution from that analysis is not possible.
- What should I look for on an olive oil label if bone metabolism is a concern?
- Look for products that declare both acidity and polyphenol content. Polyphenol levels in EVOO vary widely — from a few hundred mg/kg to considerably higher — depending on cultivar, harvest timing, and processing method. Early-harvest, single-cultivar oils tend to have higher polyphenol counts. Labels that carry this information allow for more consistent intake of the bioactive compounds studied in the research reviewed here.
Related reading
- Olive Oil, Cortisol, and Dietary Fat: Where the Research Actually Stands
Chronic stress and elevated cortisol have become defining health concerns of our time. A growing body of research is examining whether the type of dietary fat we consume — extra virgin olive oil in particular — may be linked to how the body regulates its stress response.
- Menopause, Dietary Fat, and EVOO: A Guide to the Growing Research
As estrogen levels decline during menopause, the quality of dietary fat may play a meaningful role in everyday wellbeing. EVOO research in this area is expanding — here is what the evidence currently shows.
- Beyond BMI: Dietary Fat Quality, Olive Oil, and Metabolic Health Research
Two people can share the same BMI and yet show markedly different blood lipid profiles, insulin sensitivity, and visceral fat distribution. A growing body of clinical research suggests that the type of fat consumed — not just total calories — may be a meaningful variable in metabolic health.
- Fasting Lipids, LDL Particle Size, and the Case for Olive Oil at Breakfast
Research into fasting blood lipid profiles is shifting attention from total LDL numbers toward particle size and quality — and olive oil's monounsaturated fats and polyphenols are central to that conversation.
- Senescent Cells, Senolytics, and the Question of Olive Oil Polyphenols
The senolytic diet hypothesis has drawn attention to plant polyphenols as potential allies against aging cells. This guide maps where extra virgin olive oil's oleocanthal and related phenolic compounds currently sit in that research — and what the evidence cannot yet support.
- Fat Quality, Not Quantity: Olive Oil's Place in a CKD Diet
Chronic kidney disease management has long focused on restricting protein, potassium, and phosphorus — but researchers are now turning attention to the type of fat patients consume. Here is what the current evidence says about unsaturated fats, olive oil polyphenols, and kidney function.
